A Kaplan-Meier analysis showed that a reduction in NEIL1 expression was associated with a poorer outcome in patients with breast invasive carcinoma (P = 0.0025, log-rank test) (Figure 2(e)) but not in patients with the other 12 cancer types. This evidence concerns the gene NEIL1 and cancer.